The prostate malignant neoplasms mortality in Canada is on a gradual upward trend. From 2024 to 2028, forecasted data shows an incremental increase year by year, moving from 4.73 thousand male deaths in 2024 to 4.93 thousand in 2028. Back in 2023, the actual number stood at 4.68 thousand male deaths, marking a consistent increase.
Year-on-year percentage variations indicate small, but steady increments: 1.06% in 2025, 1.04% in 2026, 1.04% in 2027, and finally 1.02% in 2028. The five-year compound annual growth rate (CAGR) reveals an average growth of approximately 1.06% per year.
Future trends to watch for include advancements in screening technologies, public health initiatives, and treatment innovations, which may influence the mortality rate either by stemming the increase or potentially reversing the upward trend, particularly if breakthroughs occur in early detection or medical interventions.
